Top Markets
#1 CyberDEX CyberDEX +678.12%
#2 龙虾 (Lobster) 龙虾 (Lobster) +27.21%
#3 GEKKO GEKKO +23.15%
#4 Harmony Harmony +21.88%
#5 PumpMeme PumpMeme +18.57%
#6 Stargate Finance Stargate Finance +18.34%
#7 LayerZero LayerZero +18.29%
#8 Starknet Starknet +17.27%
#9 Zama Zama +16.13%
#10 DexNet DexNet +15.52%
Coin of the day
CyberDEX CyberDEX
Settings
Language
ENGLISH
Currency
USD
Theme
Aoxing Pharmaceutical Company, Inc. Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc.

AOXG
Rank in Stocks #38632
Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer... Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer primarily operating within the People's Republic of China. The company dedicates itself to the research, development, production, and distribution of pharmaceutical products, with a strong emphasis on narcotics, pain management solutions, and addiction treatments. Its current product portfolio includes Zhongtong'an, a capsule derived from herbal extracts used for relieving oral and dental discomfort; Yiqi Qiangshen Granule, an over-the-counter herbal preparation designed to invigorate qi, strengthen the body, and improve blood flow by clearing meridian blockages; and Tilidine hydrochloride. The latter is an oral synthetic narcotic analgesic tablet, available in 50mg or 100mg doses, prescribed for the alleviation of acute, moderate to severe pain, as well as chronic pain associated with cancer. Aoxing also boasts several promising products in its development pipeline. These include Oxycodone and Acetaminophen tablets and capsules, which have successfully completed clinical trials for both acute and chronic pain management. Another is Buprenorphine/Naloxone, a sublingual combination tablet that has finished Phase II clinical trials as a treatment for opioid dependence. Furthermore, a Tilidine/Naloxone compound capsule is currently undergoing Phase II clinical trials, targeting acute and chronic pain. Initially known as China Aoxing Pharmaceutical Company, Inc., the firm rebranded to Aoxing Pharmaceutical Company, Inc. in March 2010. Its corporate headquarters are situated in Shijiazhuang, China.
Share Price
$0.0022
Last synced: 2026-10-02
Market Cap
$838.66K
Change (1 day)
0.00%
Change (1 year)
-77.55%
Country
US
Trade Aoxing Pharmaceutical Company, Inc. (AOXG)

Category

Healthcare
Operating Margin for Aoxing Pharmaceutical Company, Inc. (AOXG)
Operating Margin as of 2026 TTM: 0.00%
According to Aoxing Pharmaceutical Company, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Aoxing Pharmaceutical Company, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
62.34% -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00% -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00% -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
29.76% -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00% -
IT
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.